logo
搜索
菜单

JoVE Core 视频 在线看

当前272/319页
排序: 本周浏览数
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism 01:24 min
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism
13.14: Pharmacokinetics in Pediatric Patients: Drug Excretion 01:26 min
13.14: Pharmacokinetics in Pediatric Patients: Drug Excretion
13.17: Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test 01:22 min
13.17: Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
13.19: Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate 01:25 min
13.19: Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance 01:25 min
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
13.21: Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration 01:28 min
13.21: Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
13.23: Modified-Release Drug Delivery Systems: Rate-Programmed II 01:19 min
13.23: Modified-Release Drug Delivery Systems: Rate-Programmed II
13.24: Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis 01:30 min
13.24: Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
13.25: Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration 01:25 min
13.25: Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu 01:29 min
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
14.4: Pharmacogenetics of Drug Metabolism: Overview 01:27 min
14.4: Pharmacogenetics of Drug Metabolism: Overview
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase 01:27 min
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase 01:11 min
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship 01:14 min
15.3: Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship 01:23 min
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration 01:23 min
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.8: Pharmacodynamic Responses: Different Types 01:03 min
15.8: Pharmacodynamic Responses: Different Types
15.9: Pharmacodynamic Models: Overview 01:27 min
15.9: Pharmacodynamic Models: Overview
返回顶部